Adefovir dipivoxil clinical trials
Also written Hepsera.
A product of Adefovir; its studies count on that page too.
How each study uses adefovir dipivoxil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 20 Sept 2002 · HEPSERA · NDA 021449 (FDA, Drugs@FDA)
- European Union
- 6 Mar 2003 · Hepsera · EMEA/H/C/000485 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2006 (5)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 24 · Other 17
Gilead Sciences (15) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · GlaxoSmithKline (5) · Thomas Jefferson University (1) · Columbia University (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Third Affiliated Hospital, Sun Yat-Sen University (1) · Hoffmann-La Roche (1)
Often tested with
Tested in the same studies.
Lamivudine (5) · Efavirenz (4) · Telbivudine (3) · Nelfinavir (2) · Tenofovir (2) · Abacavir (2) · Amprenavir (2) · Indinavir (2)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Adefovir
- One of Reverse transcriptase inhibitors source
Studies
Open first, then newest update. How each study uses adefovir dipivoxil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 41
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedPhase 4Thomas Jefferson UniversityNCT00307242Written as Adefovir DipivoxilHow we know
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000892Written as Adefovir dipivoxilHow we know
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00033163Written as Adefovir dipivoxilHow we know
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00051077Written as Adefovir dipivoxilHow we know
- A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000912Written as Adefovir dipivoxilHow we know
- Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive LiverCompletedPhase 1/2Columbia UniversityNCT01146808Written as Adefovir dipivoxil and hepatitis B vaccinationHow we know
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT00973219Written as Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarateHow we know
- A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT01521975Written as Telbivudine, Adefovir dipivoxilHow we know
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedPhase 3Hoffmann-La RocheNCT00661076Written as adefovir dipivoxilHow we know
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedPhase 3NovartisNCT00115245Written as Adefovir DipivoxilHow we know
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownPhase 4Asian-Pacific Alliance of Liver Disease, BeijingNCT02327689Written as Emtricitabine plus adefovir dipivoxilHow we know
- The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected PatientsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00001082Written as Adefovir dipivoxilHow we know
- Effect of Age on the Renal Clearance of AdefovirWithdrawnPhase 4University of California, San FranciscoNCT00187746Written as Adefovir dipivoxilHow we know
- A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male SubjectsCompletedPhase 1Bukwang PharmaceuticalNCT01581242Written as Clevudine, Adefovir dipivoxil , Clevudine+Adefovir dipivoxilHow we know
- Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or CirrhosisCompletedPhase 4GlaxoSmithKlineNCT00347009Written as adefovir dipivoxilHow we know
- Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis BCompletedPhase 3Gilead SciencesNCT00095121Written as Adefovir Dipivoxil (ADV)How we know
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownPhase 4Jun ChengNCT01436539Written as Adefovir Dipivoxil and polyene phosphatidylcholineHow we know
- Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814CompletedPhase 4GlaxoSmithKlineNCT00403585Written as adefovir dipivoxil 10mgHow we know
- A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyStatus unknownNot applicableHospital Authority, Hong KongNCT00489151Written as adefovir dipivoxilHow we know
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis BCompletedPhase 4GlaxoSmithKlineNCT00324961Written as adefovir dipivoxil tabletsHow we know
See all 41 studies that test adefovir dipivoxil →
Given beside what is tested · 2 — adefovir dipivoxil is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with adefovir dipivoxil
- Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)CompletedPhase 3GlaxoSmithKlineNCT01300234Written as Adefovir dipivoxil (ADV) tabletsHow we know
- Lamivudine and Adefovir Dipivoxil Fixed Dose CombinationCompletedPhase 1GlaxoSmithKlineNCT01353742Written as Adefovir dipivoxilHow we know
- PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)CompletedPhase 3Merck Sharp & Dohme LLCNCT00371761Written as Adefovir dipivoxil (adefovir)How we know
- A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis BCompletedPhase 3Gilead SciencesNCT00116805Written as ADVHow we know
- A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis BCompletedPhase 3Gilead SciencesNCT00117676Written as ADVHow we know
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedPhase 4Hoffmann-La RocheNCT02598063Written as Adefovir dipivoxilHow we know
- A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-BCompletedPhase 3Bukwang PharmaceuticalNCT00672867Written as Adefovir dipivoxilHow we know
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnPhase 4NovartisNCT00606099Written as adefovir dipivoxilHow we know
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedPhase 4Bukwang PharmaceuticalNCT00641082Written as Adefovir dipivoxilHow we know
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis BStatus unknownPhase 2Huntington Medical Research InstitutesNCT00753467Written as Adefovir dipivoxilHow we know
Codes
What other systems call adefovir dipivoxil · ClinicalTrials.gg INT004000
- MeSH (NLM) C106812adefovir dipivoxilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U6Q8Z01514ADEFOVIR DIPIVOXILConfirmed FDA, NLM, Wikidata
- RxNorm 141400Confirmed FDA, Wikidata
- Wikidata Q28851735adefovir dipivoxilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28811Adefovir DipivoxilConfirmed FDA, Wikidata
- DrugBank DB00718One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C106812 | adefovir dipivoxil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U6Q8Z01514 | ADEFOVIR DIPIVOXIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 141400 | — | Confirmed FDA, Wikidata |
| Wikidata | Q28851735 | adefovir dipivoxil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28811 | Adefovir Dipivoxil | Confirmed FDA, Wikidata |
| DrugBank | DB00718 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.